Skip to main content
Have a personal or library account? Click to login
Ectromelia Virus Reprograms the Noncanonical NF-κB Signaling Pathway in HeLa Epithelial Cells Cover

Ectromelia Virus Reprograms the Noncanonical NF-κB Signaling Pathway in HeLa Epithelial Cells

Open Access
|Oct 2026

References

  1. Alejo A, Ruiz-Argüello MB, Pontejo SM et al. (2018) Chemokines cooperate with TNF to provide protective anti-viral immunity and to enhance inflammation. Nat Commun 9:1790. https://doi.org/10.1038/s41467-018-04098-8
  2. Alvarez-de Miranda FJ, Alonso-Sánchez I, Alcamí A et al. (2021) TNF decoy receptors encoded by poxviruses. Pathogens 10:1065. https://doi.org/10.3390/pathogens10081065
  3. Bai W, Huo S, Li J et al. (2022) Advances in the study of the ubiquitin-editing enzyme A20. Front Pharmacol 13:845262. https://doi.org/10.3389/fphar.2022.845262
  4. Bernard D, Quatannens B, Vandenbunder B et al. (2001) Rel/NF-κB transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1. J Biol Chem 276:27322–27328. https://doi.org/10.1074/jbc.M011183200
  5. Boratyńska A, Martyniszyn L, Szulc L et al. (2010) Contribution of rearranged actin structures to the spread of ectromelia virus infection in vitro. Acta Virol 54:41–48. https://doi.org/10.4149/av_2010_01_41
  6. Brady G, Bowie AG (2014) Innate immune activation of NFκB and its antagonism by poxviruses. Cytokine Growth Factor Rev 25:611–620. https://doi.org/10.1016/j.cytogfr.2014.07.004
  7. Bren GD, Solan NJ, Miyoshi H et al. (2001) Transcription of the RelB gene is regulated by NF-κB. Oncogene 20:7722–7733. https://doi.org/10.1038/sj.onc.1204868
  8. Bustin SA, Benes V, Garson JA et al. (2009) The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611–622. https://doi.org/10.1373/clinchem.2008.112797
  9. Chawla M, Roy P, Basak S (2021) Role of the NF-κB system in context-specific tuning of the inflammatory gene response. Curr Opin Immunol 68:21–27. https://doi.org/10.1016/j.coi.2020.08.005
  10. Cheng WY, He XB, Jia HJ et al. (2018) The cGas-Sting signaling pathway is required for the innate immune response against ectromelia virus. Front Immunol 9:1297. https://doi.org/10.3389/fimmu.2018.01297
  11. Desai P, Tahiliani V, Hutchinson TE et al. (2018) The TNF superfamily molecule LIGHT promotes the generation of circulating and lung-resident memory CD8 T cells following an acute respiratory virus infection. J Immunol 200:2894–2904. https://doi.org/10.4049/jimmunol.1701499
  12. D'lgnazio L, Batie M, Rocha S (2018) TNFSF14/LIGHT, a non-canonical NF-κB stimulus, induces the HIF pathway. Cells 7:102. https://doi.org/10.3390/cells7080102
  13. Diven DG (2001) An overview of poxviruses. J Am Acad Dermatol 44:1–16. https://doi.org/10.1067/mjd.2001.109302
  14. Gao Z, Zheng T, Wu J et al. (2025) Sterilized protective immunity induced by DAM and DAM+ in mouse models for both VACV and MPXV. Sci Bull 70:2514–2524. https://doi.org/10.1016/j.scib.2025.05.013
  15. Garver J, Weber L, Vela EM et al. (2016) Ectromelia virus disease characterization in the BALB/c mouse: A surrogate model for assessment of smallpox medical countermeasures. Viruses 8:203. https://doi.org/10.3390/v8070203
  16. Gieryńska M, Szulc-Dąbrowska L, Struzik J et al. (2023) Orthopoxvirus zoonoses—do we still remember and are ready to fight? Pathogens 12:363. https://doi.org/10.3390/pathogens12030363
  17. Harbour JC, Abdelbary M, Schell JB et al. (2023) T helper 1 effector memory CD4+ T cells protect the skin from poxvirus infection. Cell Rep 42:112407. https://doi.org/10.1016/j.celrep.2023.112407
  18. Hauer J, Püschner S, Ramakrishnan P et al. (2005) TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs. Proc Natl Acad Sci USA 102:2874–2879. https://doi.org/10.1073/pnas.0500187102
  19. Hernaez B, Alcamí A (2024) Poxvirus immune evasion. Annu Rev Immunol 42:551–584. https://doi.org/10.1146/annurevimmunol-090222-110227
  20. Hou Y, Wang Y, Chen J et al. (2022) Dual roles of tumor necrosis factor superfamily 14 in antiviral immunity. Viral Immunol 35:579–585. https://doi.org/10.1089/vim.2022.0070
  21. Hsieh SL, Lin WW (2017) Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions. J Biomed Sci 24:39. https://doi.org/10.1186/s12929-017-0347-7
  22. Hsu J, Kim S, Anandasabapathy N (2024) Vaccinia virus: Mechanisms supporting immune evasion and successful long-term protective immunity. Viruses 16:870. https://doi.org/10.3390/v16060870
  23. Hu H, Brittain GC, Chang JH et al. (2013) OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3. Nature 494:371–374. https://doi.org/10.1038/nature11831
  24. Huston J, Curtis S, Egelund EF (2023) Brincidofovir: A novel agent for the treatment of smallpox. Ann Pharmacother 57:1198–1206. https://doi.org/10.1177/10600280231151751
  25. Jin J, Hu H, Li HS et al. (2014) Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity. Immunity 40:342–354. https://doi.org/10.1016/j.immuni.2014.02.006
  26. Kangbai JB, Sesay U, Vickos U et al. (2025) Mpox in Africa: What we know and what is still lacking. PLoS Negl Trop Dis 19:e0013148. https://doi.org/10.1371/journal.pntd.0013148
  27. Kaszycki J, Kim M (2025) Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-κB signaling pathways. Front Immunol 16:1529756. https://doi.org/10.3389/fimmu.2025.1529756
  28. Kim YS, Nedospasov SA, Liu ZG (2005) TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin β receptor signaling. Mol Cell Biol 25:2130–2137. https://doi.org/10.1128/MCB.25.6.2130-2137.2005
  29. Koroleva EP, Fu YX, Tumanov AV (2018) Lymphotoxin in physiology of lymphoid tissues - implication for antiviral defense. Cytokine 101:39–47. https://doi.org/10.1016/j.cyto.2016.08.018
  30. Kusiak A, Brady G (2022) Bifurcation of signalling in human innate immune pathways to NF-κB and IRF family activation. Biochem Pharmacol 205:115246. https://doi.org/10.1016/j.bcp.2022.115246
  31. Lawler C, Brady G (2020) Poxviral targeting of interferon regulatory factor activation. Viruses 12:1191. https://doi.org/10.3390/v12101191
  32. Liu T, Zhang L, Joo D et al. (2017) NF-κB signaling in inflammation. Signal Transduct Target Ther 2:17023. https://doi.org/10.1038/sigtrans.2017.23
  33. Madge LA, May MJ (2010) Classical NF-κB activation negatively regulates noncanonical NF-κB-dependent CXCL12 expression. J Biol Chem 285:38069–38077. https://doi.org/10.1074/jbc.M110.147207
  34. Mahoney DJ, Cheung HH, Mrad RL et al. (2008) Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation. Proc Natl Acad Sci USA 105:11778–11783. https://doi.org/10.1073/pnas.0711122105
  35. Mordmüller B, Krappmann D, Esen M et al. (2003) Lymphotoxin and lipopolysaccharide induce NF-κB-p52 generation by a co-translational mechanism. EMBO Rep 4:82–87. https://doi.org/10.1038/sj.embor.embor710
  36. Norris PS, Ware CF (2007) The LTβR signaling pathway. In: Wu H (ed) TNF receptor associated factors (TRAFs). Advances in experimental medicine and biology, Vol. 597. Springer, New York, pp. 160–172. https://doi.org/10.1007/978-0-387-70630-6_13
  37. Parvatiyar K, Pindado J, Dev A et al. (2018) A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling. Nat Commun 9:2770. https://doi.org/10.1038/s41467-018-05168-7
  38. Piao W, Kasinath V, Saxena V et al. (2021) LTβR signaling controls lymphatic migration of immune cells. Cells 10:747. https://doi.org/10.3390/cells10040747
  39. Pontejo SM, Alejo A, Alcami A (2015) Comparative biochemical and functional analysis of viral and human secreted tumor necrosis factor (TNF) decoy receptors. J Biol Chem 290:15973–15984. https://doi.org/10.1074/jbc.M115.650119
  40. Prakash S, Robbins PW (2001) Fibrosin: a novel lymphokine in wound healing. Exp Mol Pathol 71:247–255. https://doi.org/10.1006/exmp.2001.2402
  41. Prakash S, Robbins PW, Wyler DJ (1995) Cloning and analysis of murine cDNA that encodes a fibrogenic lymphokine, fibrosin. Proc Natl Acad Sci USA 92:2154–2158. https://doi.org/10.1073/pnas.92.6.2154
  42. Rauert H, Wicovsky A, Müller N et al. (2010) Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2). J Biol Chem 285:7394–7404. https://doi.org/10.1074/jbc.M109.037341
  43. Razani B, Zarnegar B, Ytterberg AJ et al. (2010) Negative feedback in noncanonical NF-κB signaling modulates NIK stability through IKKα-mediated phosphorylation. Sci Signal 3:ra41. https://doi.org/10.1126/scisignal.2000778
  44. Reus JB, Rex EA, Gammon DB (2022) How to inhibit nuclear factor-κB signaling: lessons from poxviruses. Pathogens 11:1061. https://doi.org/10.3390/pathogens11091061
  45. Rodriguez BN, Huang H, Chia JJ et al. (2024) The noncanonical NFκB pathway: regulatory mechanisms in health and disease. WIREs Mech Dis 16:e1646. https://doi.org/10.1002/wsbm.1646
  46. Rooney IA, Butrovich KD, Glass AA et al. (2000) The lymphotoxin-β receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J Biol Chem 275:14307–14315. https://doi.org/10.1074/jbc.275.19.14307
  47. Saha I, Jaiswal H, Mishra R et al. (2020) RelB suppresses type I Interferon signaling in dendritic cells. Cell Immunol 349:104043. https://doi.org/10.1016/j.cellimm.2020.104043
  48. Saitoh T, Nakano H, Yamamoto N et al. (2002) Lymphotoxin-β receptor mediates NEMO-independent NF-κB activation. FEBS Lett 532:45–51. https://doi.org/10.1016/s0014-5793(02)03622-0
  49. Savenkova DA, Gudymo AS, Korablev AN et al. (2024) Knockout of the Tnfa gene decreases influenza virus-induced histological reactions in laboratory mice. Int J Mol Sci 25:1156. https://doi.org/10.3390/ijms25021156
  50. Šedý J, Bekiaris V, Ware CF (2014) Tumor necrosis factor superfamily in innate immunity and inflammation. Cold Spring Harb Perspect Biol 7:a016279. https://doi.org/10.1101/cshperspect.a016279
  51. Shehata AA, Parvin R, Tasnim S et al. (2025) The hidden threat: rodent-borne viruses and their impact on public health. Viruses 17:809. https://doi.org/10.3390/v17060809
  52. Struzik J, Szulc-Dąbrowska L (2019) Manipulation of non-canonical NF-κB signaling by non-oncogenic viruses. Arch Immunol Ther Exp 67:41–48. https://doi.org/10.1007/s00005-018-0522-x
  53. Struzik J, Szulc-Dąbrowska L, Mielcarska MB et al. (2020) First insight into the modulation of noncanonical NF-κB signaling components by poxviruses in established immune-derived cell lines: An in vitro model of ectromelia virus infection. Pathogens 9:814. https://doi.org/10.3390/pathogens9100814
  54. Sun SC (2017) The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol 17:545–558. https://doi.org/10.1038/nri.2017.52
  55. Suo F, Zhou X, Setroikromo R et al. (2022) Receptor specificity engineering of TNF superfamily ligands. Pharmaceutics 14:181. https://doi.org/10.3390/pharmaceutics14010181
  56. Szulc-Dąbrowska L, Biernacka Z, Koper M et al. (2023) Differential activation of splenic cDC1 and cDC2 cell subsets following poxvirus infection of BALB/c and C57BL/6 mice. Cells 13:13. https://doi.org/10.3390/cells13010013
  57. Szulc-Dąbrowska L, Struzik J, Cymerys J et al. (2017) The in vitro inhibitory effect of ectromelia virus infection on innate and adaptive immune properties of GM-CSF-derived bone marrow cells is mouse strain-independent. Front Microbiol 8:2539. https://doi.org/10.3389/fmicb.2017.02539
  58. Tas SW, Bryant VL, Cook MC (2023) Editorial: non-canonical NF-κB signaling in immune-mediated inflammatory diseases and malignancies. Front Immunol 14:1252939. https://doi.org/10.3389/fimmu.2023.1252939
  59. Tully JE, Nolin JD, Guala AS et al. (2012) Cooperation between classical and alternative NF-κB pathways regulates proinflammatory responses in epithelial cells. Am J Respir Cell Mol Biol 47:497–508. https://doi.org/10.1165/rcmb.2012-0014OC
  60. van Buuren N, Burles K, Schriewer J et al. (2014) EVM005: An ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence. PLoS Pathog 10:e1004326. https://doi.org/10.1371/journal.ppat.1004326
  61. Vereecke L, Beyaert R, van Loo G (2011) Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. Biochem Soc Trans 39:1086–1091. https://doi.org/10.1042/BST0391086
  62. Wang CY, Mayo MW, Korneluk RG et al. (1998) NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281:1680–1683. https://doi.org/10.1126/science.281.5383.1680
  63. Willuveit AL, Stefanini ACB, Matozo T et al. (2025) CCR10: a comprehensive review of its function, phylogeny, role in immune cell trafficking and disease pathogenesis. Front Immunol 16:1599277. https://doi.org/10.3389/fimmu.2025.1599277
  64. Wyler DJ (1996) Fibrosin, a novel fibrogenic protein: discovery, cloning and implications for fibrotic disorders. Int Arch Allergy Immunol 111:326–329. https://doi.org/10.1159/000237388
  65. Xie X, Jin J, Zhu L et al. (2019) Cell type-specific function of TRAF2 and TRAF3 in regulating type I IFN induction. Cell Biosci 9:5. https://doi.org/10.1186/s13578-018-0268-5
  66. Xie W, Tian S, Yang J et al. (2022) OTUD7B deubiquitinates SQSTM1/p62 and promotes IRF3 degradation to regulate antiviral immunity. Autophagy 18:2288–2302. https://doi.org/10.1080/15548627.2022.2026098
  67. Yahya G, Mohamed NH, Wadan AS et al. (2026) The emerging threat of monkeypox: an updated overview. Viruses 18:69. https://doi.org/10.3390/v18010069
  68. Yamaguchi N, Oyama M, Kozuka-Hata H et al. (2013) Involvement of A20 in the molecular switch that activates the non-canonical NF-κB pathway. Sci Rep 3:2568. https://doi.org/10.1038/srep02568
  69. Yu H, Lin L, Zhang Z et al. (2020) Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target Ther 5:209. https://doi.org/10.1038/s41392-020-00312-6
  70. Zammit NW, Siggs OM, Gray PE et al. (2019) Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity. Nat Immunol 20:1299–1310. https://doi.org/10.1038/s41590-019-0492-0
Language: English
Submitted on: Mar 20, 2026
Accepted on: Aug 10, 2026
Published on: Oct 18, 2026
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Justyna Struzik, Lidia Szulc-Dąbrowska, Michał Koper, Małgorzata Gieryńska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution 4.0 License.